加拿大国民银行 FI 提高了 AmeriSourceBergen Co. 的股票头寸（纽约证券交易所：ABC）|加拿大_新浪财经

National Bank of Canada FI lifted its position in AmerisourceBergen Co. (NYSE:ABC – Get Rating) by 74.5% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 35,396 shares of the company's stock after purchasing an additional 15,117 shares during the quarter. National Bank of Canada FI's holdings in AmerisourceBergen were worth $5,865,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the company. Profund Advisors LLC boosted its holdings in shares of AmerisourceBergen by 2.9% in the 3rd quarter. Profund Advisors LLC now owns 2,317 shares of the company's stock worth $314,000 after purchasing an additional 65 shares in the last quarter. Vantage Consulting Group Inc boosted its holdings in shares of AmerisourceBergen by 4.7% in the 3rd quarter. Vantage Consulting Group Inc now owns 1,482 shares of the company's stock worth $201,000 after purchasing an additional 66 shares in the last quarter. J2 Capital Management Inc lifted its stake in shares of AmerisourceBergen by 2.5% in the 4th quarter. J2 Capital Management Inc now owns 2,682 shares of the company's stock valued at $444,000 after acquiring an additional 66 shares during the last quarter. Farmers Trust Co. lifted its stake in shares of AmerisourceBergen by 0.7% in the 4th quarter. Farmers Trust Co. now owns 9,765 shares of the company's stock valued at $1,618,000 after acquiring an additional 72 shares during the last quarter. Finally, Donald L. Hagan LLC lifted its stake in shares of AmerisourceBergen by 1.2% in the 4th quarter. Donald L. Hagan LLC now owns 6,082 shares of the company's stock valued at $1,008,000 after acquiring an additional 75 shares during the last quarter. 84.79% of the stock is currently owned by hedge funds and other institutional investors.

Get

AmerisourceBergen

alerts:

AmerisourceBergen Stock Down 0.6 %

Shares of NYSE:ABC opened at $166.35 on Friday. AmerisourceBergen Co. has a 52-week low of $135.14 and a 52-week high of $174.63. The firm has a market capitalization of $33.65 billion, a P/E ratio of 20.19, a P/E/G ratio of 1.60 and a beta of 0.52. The stock has a 50 day moving average price of $157.40 and a 200-day moving average price of $157.31. The company has a debt-to-equity ratio of 63.30, a quick ratio of 0.53 and a current ratio of 0.91.

AmerisourceBergen (NYSE:ABC – Get Rating) last announced its earnings results on Wednesday, February 1st. The company reported $2.71 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.62 by $0.09. AmerisourceBergen had a return on equity of 597.57% and a net margin of 0.72%. The firm had revenue of $62.85 billion during the quarter, compared to analyst estimates of $62.77 billion. During the same quarter in the prior year, the company earned $2.58 EPS. The business's revenue was up 5.4% compared to the same quarter last year. As a group, equities research analysts anticipate that AmerisourceBergen Co. will post 11.61 EPS for the current fiscal year.

AmerisourceBergen Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, February 27th. Stockholders of record on Friday, February 10th were given a $0.485 dividend. This represents a $1.94 annualized dividend and a dividend yield of 1.17%. The ex-dividend date was Thursday, February 9th. AmerisourceBergen's dividend payout ratio is currently 23.54%.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on ABC shares. Mizuho boosted their target price on AmerisourceBergen from $162.00 to $170.00 and gave the company a "neutral" rating in a research note on Thursday, February 2nd. UBS Group boosted their target price on AmerisourceBergen from $184.00 to $190.00 and gave the company a "buy" rating in a research note on Tuesday, January 31st. Argus boosted their target price on AmerisourceBergen from $170.00 to $190.00 and gave the company a "buy" rating in a research note on Thursday, January 12th. StockNews.com started coverage on AmerisourceBergen in a research note on Thursday, March 16th. They issued a "strong-buy" rating for the company. Finally, Robert W. Baird boosted their target price on AmerisourceBergen from $199.00 to $201.00 and gave the company an "outperform" rating in a research note on Thursday, February 2nd. Two investment analysts have rated the stock with a hold rating, twelve have given a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus target price of $180.46.

Insider Transactions at AmerisourceBergen

In related news, CEO Steven H. Collis sold 10,499 shares of the company's stock in a transaction that occurred on Tuesday, March 14th. The stock was sold at an average price of $150.00, for a total value of $1,574,850.00. Following the sale, the chief executive officer now owns 257,967 shares in the company, valued at approximately $38,695,050. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In related news, CEO Steven H. Collis sold 10,499 shares of the company's stock in a transaction that occurred on Tuesday, March 14th. The stock was sold at an average price of $150.00, for a total value of $1,574,850.00. Following the sale, the chief executive officer now owns 257,967 shares in the company, valued at approximately $38,695,050. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Gina Clark sold 1,924 shares of the company's stock in a transaction that occurred on Wednesday, March 1st. The stock was sold at an average price of $156.22, for a total value of $300,567.28. Following the completion of the sale, the executive vice president now owns 26,733 shares in the company, valued at approximately $4,176,229.26. The disclosure for this sale can be found here. In the last quarter, insiders sold 28,633 shares of company stock valued at $4,490,081. Corporate insiders own 20.10% of the company's stock.

AmerisourceBergen Company Profile

(Get Rating)

AmerisourceBergen Corp. engages in the provision of pharmaceutical products and business solutions that improve access to care. It operates through the Pharmaceutical Distribution Services and Other segments. The Pharmaceutical Distribution Services segment distributes an offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, and long-term care and alternate site pharmacies.